Mate, joke aside, one last time. PCK is as de-risked as any speculative stock can be at this stage of its life. It has TGA and CE mark approval. It has full support of both Dementia Australia and Dementia USA. It has multiples of peer reviewed documents. It has the creator of Abbey Pain Scale on board. It has the Federal Government support in the form of an initial $5m grant. It has been in used in more than 80 aged care facilities already plus a few of them have re-signed and so far, no churn rate. It is a Monopoly in this space. It has recently signed a deal with a company to market Painchek into the UK market. And more international market deals to come. Seriously, what more do you need? A competent management team? Well, we have Philip Daffas as the CEO to guide this company through to complete fruition of its plan. He has done this before and will do this again.
Anyway, if you must go, go with my blessing. Good luck to you as well.
PainChek General Discussion, page-3269
-
- There are more pages in this discussion • 17,144 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
-0.002(5.88%) |
Mkt cap ! $52.34M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.1¢ | $9.469K | 294.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 111485 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 15.57pm 12/09/2024 (20 minute delay) ? |
| PCK (ASX) Chart |